Anticancer Technology | DEB-TACE: A New Generation of Transcatheter Arterial Chemoembolization (TACE)

Multimedia Centermore

Breakthrough: Minimally Invasive Therapy Overturns Terminal Diagnosis Tongue Cancer ≠ Tongue Removal｜A Malaysian Chinese’s Miracle of Minimally Invasive Tongue Preservation Treatment 10 Years of Anti-Cancer Advocacy by Malaysia International Service Center Persistent Breast Tumor Ulceration and Bleeding: Hemostasis and Tumor Reduction Achieved in 18 Days with Interventional Therapy Late-Stage Gastric Cancer: 90% of Tumors Eliminated in 3 Months, Remarkable Results with Integrated Minimally Invasive Therapy Minimally Invasive Comprehensive Therapy: Restoring a Face Consumed by Tumor A Stage IV Nasopharyngeal Carcinoma Triumph: Emerging from Despair to Paint a New Chapter of Life Warm Retrospective of the 5th ASEAN International Integrative Oncology Medicine Session · Malaysia | United by Integration

Treatment Technologiesmore

Interventional Therapy Cryotherapy Combined Knife Nanoknife Technology Microwave Ablation Particle Knife Photodynamic Therapy Photon Knife Therapy

MDT Teammore

Chief Expert of Oncology Department

Chief physician

Song Shijun, professor, chief physician, CPC member, has been engaged in clinical work of oncology for more than 40 years, and was the deputy director of medical oncology department of the Third Affiliated Hospital of Xinxiang Medical College. He specializes in chemotherapy, minimally invasive therapy, biotherapy and targeted therapy for various solid tumors, especially in the treatment of thoracic tumors such as esophageal cancer, lung cancer, breast cancer, lymphoma, etc. and digestive tumors such as gastric cancer, colorectal cancer and other tumors;

Director of Oncology Department, Director of Breast Cancer Center

Chief Physician

She specializes in various minimally invasive treatments for tumors, especially chemotherapy, targeted therapy and various integrated minimally invasive treatment measures and individualized treatments for breast cancer, lung cancer, gastrointestinal cancer, and gynecological tumors.

Director of Oncology Department

Associate Chief Physician

Ma Xiaoying, more than 20 years experience of clinical work in oncology, and is currently a member of the Specialized Committee on Medical Oncology, Chinese Anti-Cancer Association (CACA ) and member of Specialized Committee of Tumor Endoscopy. She specializes in chemotherapy, endocrine therapy, molecular targeted therapy and immunotherapy for various malignant tumors, including digestive tract tumors, breast cancer, lung cancer, gynecological tumors, genitour and genitourinary tumors, as well as the treatment of advanced and refractory tumors. also familiar with the minimally invasive treatment of various malignant tumors. especially for the treatment of advanced and refractory tumors with rich clinical experience. meanwhile she has published many academic thesis in professional journals.

Deputy Director, International Oncology Ward

Associate Chief Physician

Dr. Lin Jing has been engaged in clinical work in oncology for nearly 20 years and is currently a member of the Chinese Anti-Cancer Association. She specializes in minimally invasive targeted therapy, immunotherapy, chemotherapy, radiotherapy and endocrine therapy, and other comprehensive treatments for solid tumors such as breast cancer, esophageal cancer, gastric cancer, intestinal cancer, hepatocellular carcinoma, lung cancer, gynecological tumors, etc. She is also good at gastrointestinal examination, endoscopic jejunal nutritional tube implantation, and endoscopic photodynamic therapy. She is familiar with the principles of various minimally invasive treatments such as intervention, argon-helium cryotherapy, radiofrequency ablation, etc. She is skilled in the prevention of various tumor complications and the diagnosis and treatment of critical illnesses.

Oncology Specialist

Associate Chief Physician

Specialized in personalized comprehensive treatment for complex cancers including lung cancer, liver cancer, colon cancer, gastric cancer, esophageal cancer, ovarian cancer, and cervical cancer. Skilled in interventional minimally invasive therapy, chemotherapy, and combined targeted-immunotherapy.

Patient Storiesmore

Prostate cancer

Mr.Chen

Malaysiamore than 1 year

Mr.Chen was diagnosed prostate cancer, the local doctor suggested him to undergo a direct resection, but Mr.TING wanted to live a life like normal people, so he came to St. Stamford Modern Cancer Hospital Guangzhou for help.

Endometrial Cancer

FOO AI KIM

Malaysiaover 2 years

When life struck her with a series of devastating blows, 59-year-old Malaysian Chinese FOO AI KIM once believed she was nearing the final chapter of her life’s story. Yet, her cross-border journey for treatment—from Malaysia to China—ultimately turned the page to a brand new beginning. Sudden Onset of Illness: From “ Conventional Treatment ” to Abandoning Therapy In September 2024, FOO AI KIM, who had already entered menopause and stopped menstruating, suddenly experienced irregular periods with heavy bleeding. After being examined at a local hospital in Malaysia, doctors advised her to undergo an immediate hysterectomy. The postoperative pathological results came as a shock to everyone—endometrial cancer. Following the local conventional approach of “removing the problem when it arises”, she subsequently began a five-week treatment plan: five sessions of chemotherapy and 25 sessions of radiotherapy. (FOO AI KIM) However, the side effects of the treatment nearly crushed

Tongue Cancer

Wu Wen Bor

MalaysiaOver 1 year

When 60-year-oldWu Wen Bordiscovered that a smalllumpon his tongue tip was a highly active cancer, he faced a brutal choice: undergo conventional treatment in Malaysia that could cost him his entire tongue, or travel to China in search of a glimmer of hope. His story is one of fear, courage, choice, and rebirth. Sudden Bad News｜ Cancer Strikes – Is “Tongue Removal” the Only Option? “The doctors said they had to remove my entire tongue. I was terrified.” In September 2024, Malaysian Chinese Wu Wen Borunexpectedly noticed a lump measuring approximately 2.21.5cm on his tongue tip. At first, he thought it was just ordinary inflammation, but the accompanying melanin deposition left him uneasy. He went to a local hospital for an excisional biopsy. The report hit him like a thunderbolt—tongue melanoma, with highly active cancer cells (Ki-67 50%). (The lump and melanin deposition on the tongue tip) After a brief recovery from the excisional biopsy at a local hospital in October 2

DEB-TACE: A New Generation of Transcatheter Arterial Chemoembolization (TACE)

2024-09-23
Share

New upgrade of TACE: DEB-TACE further improves the curative effect, and combines embolization and drug-loading functions into one, which is safe and reliable.

«PreviousCombined Knife: A new anti-cancer technology which redefine cold and heat ablation

»NextRadioactive Particle & Chemical Particle Combined Implantation